The Future of Positive Airway Pressure Devices….. COVID-19 & Its Impact….
The global positive
airway pressure devices market
size was valued at USD 1.7 billion in
2018 and is anticipated to grow at a significant rate over the forecast
period. The key factor attributing to market growth is the high economic burden
caused by sleep apnea. Sleep apnea is associated with numerous health problems
like hypertension, heart disease, depression, and diabetes, which indirectly
increases the overall economic burden on the patient. Moreover, untreated sleep
apnea leads to loss of productivity at the workplace and workplace accidents
caused due to the lack of sleep.
Unprecedented demand for mechanical
ventilators is resulting in a significant shortage of these devices in key
countries affected by the Covid-19 outbreak. The unmet demand for mechanical
ventilators is forcing biomedical engineers and scientists to create makeshift
ventilators using respiratory devices such as PAP, manual resuscitators,
nebulizers, oxygen concentrators, and others. This is acting as a pivotal
factor for the growth of PAP devices market in recent times. We at GVR are
trying to quantify the impact of this pandemic on PAP devices market. Get you
copy now to gain deeper insights on the same.
According to a study conducted by the
American Academy of Sleep Medicine (AASM) in 2016, the annual economic burden
caused due to undiagnosed sleep apnea among U.S. adults was approximately USD
149.6 billion. Whereas, treated sleep apnea would result in an annual economic
savings of over USD 100 billion in the country. Due to this, the government
institutions across various regions have started focusing on increasing the
overall treatment rate by creating awareness among citizens on obstructive
sleep apnea and its treatment, thus, boosting the demand for positive airways
pressure (PAP) machines globally.
Some of the players operating in this market
include Koninklijke Philips N.V. (Philips Respironics); Curative Medical;
ResMed; Fisher and Paykel Healthcare Limited; Drive DeVilbiss Healthcare Inc.;
and Somnetics International, Inc.
These companies are focused on new product development, strategic acquisitions,
and developing partnerships to gain higher market share. Moreover, strong
geographic presence in multiple countries, wide product portfolio, and large
number of distributors has helped the key players to strengthen their market
presence.
To Request Sample Copy of this report, click the link: https://www.grandviewresearch.com/industry-analysis/positive-airway-pressure-devices-market/request/rs2
The global positive airway pressure
devices market size is anticipated to reach USD 2.7 billion by 2025, expanding
at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. An
increase in the patient pool suffering from Obstructive Sleep Apnea (OSA) is
one of the key factors anticipated to drive the market growth. Furthermore, an
increase in the compliance rate of positive airways pressure (PAP) machines due
to growing awareness for sleep apnea and its associated disorders is likely to
drive growth over the forecast period. However, the availability of alternative
treatment options such as nasal surgery, uvulopalatopharyngoplasty (UPPP), and
mandibular maxillomandibular advancement surgery and the on-going clinical
trials for the development of sleep apnea medications are some of the major
challenges to the market growth.
Further key findings from the report
suggest:
·
The global PAP Devices market
is anticipated to be USD 2.7 billion by 2025, owing to the high prevalence of
OSA
·
CPAP devices accounted for a
major share in 2018 with a revenue of USD 1.3 billion, owing to the increasing
awareness about sleep apnea related treatments among patients
·
North America dominated the
market in 2018, owing to the availability of favorable reimbursement policies
for PAP devices in the region
·
Some of the key players are
Koninklijke Philips N.V. (Philips Respironics); Curative Medical; ResMed;
Fisher and Paykel Healthcare Limited; and Drive DeVilbiss Healthcare,
Inc.
In 2018, the CPAP device dominated the
market, with a revenue of USD 1.3 billion. The penetration of CPAP is
increasing owing to improved patient outcomes and favorable reimbursement
policies across various countries. Moreover, the launch of portable
travel-friendly CPAP machines has also influenced the growth of this segment.
On the other hand, the BiPAP device is expected to exhibit the fastest growth
rate over the forecast period, owing to its higher efficiency compared to other
PAP devices.
The
positive airway pressure device manufacturers are innovating their existing
product lines to achieve a better compliance rate. The competitors are focused
on designing comfortable masks with more stable straps, smaller breathing masks
made of soft material, and are also working on improving noise reduction
features. These have helped to improve the overall efficiency of PAP machines
and increase patient compliance.
Also,
the rise in patient compliance rate has helped drive the market for PAP
devices. Around 80% of diagnosed patients opt for PAP therapy. Most of the
insurance providers grant reimbursements only when a patient adheres to the
compliance standards for a stipulated amount of time in the first 90 days trial
period. It helps the patients in acquiring compensation from insurance
providers, which, in turn, has supported the adoption of PAP devices.
However,
the high cost associated with PAP machines is likely to obstruct the positive
airway pressure devices market. For instance, the average cost of a CPAP device
varies between USD 1000 - USD 4000 (without insurance), depending on the brand,
model of machine, and feature. Although health insurance covers the cost of
sleep apnea treatment, patients are required to bear some part of the total
cost. Moreover, the portable travel-friendly CPAP devices newly launched in the
market, are considered merely as a luxury item and hence are not covered by any
insurance coverage.
Browse Press
Release of this report:
Grand View Research has segmented the
global PAP devices market based on product type:
PAP Devices Product Type Outlook (Revenue, USD Million,
2014 - 2025)
·
CPAP
·
APAP
·
BiPAP
Based on product type, the global
market for PAP devices is classified into CPAP, APAP, and BiPAP devices. In
2018, the CPAP devices dominated the market with a revenue of USD 1.3 billion
and is anticipated to grow at a significant rate over the forecast period. CPAP
is the first line of treatment for obstructive sleep apnea and has commonly
prescribed to the patient who is suffering from snoring and episodes of
obstructed breathing during sleep. Moreover, increased adoption of these
devices due to their low cost as compared to other PAP devices has supported
the growth of this segment.
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment